Amy Abernethy - Aug 2, 2021 Form 3 Insider Report for CM Life Sciences III Inc. (EQRX)

Role
Director
Signature
/s/ Brian Emes, as Attorney-in-Fact
Stock symbol
EQRX
Transactions as of
Aug 2, 2021
Transactions value $
$0
Form type
3
Date filed
8/3/2021, 04:24 PM
Next filing
Dec 21, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding EQRX Class B common stock Aug 2, 2021 Class A common stock 200K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the issuer's initial business combination or earlier at the option of the holder as described under the heading "Description of Securities--Founder Shares" in the Issuer's registration statement on Form S-1 (File No. 333-253475) (the "Registration Statement"), on a one-for-one basis, subject to adjustment for stock splits, stock capitalizations, reorganizations, recapitalizations and the like, and certain anti-dilution rights and have no expiration date.

Remarks:

Exhibit 24.1 - Power of Attorney